Correlation between BCM (Breast Cancer Mucin) and CA 549 Serum Levels Cystic Breast Disease

Abstract

Get full access to this article

View all access options for this article.

References

Gozdz

S.S.

, Konalska

M.M.

, Slusniak

J.T.

Pretreatment concentrations of breast carcinoma antigen (CA 15.3) and mucin like carcinoma associated antigen in patients with carcinoma of the breast. Tumor Biol 1989; 10: 103–8.

Bieglmayer

, Szepezi

, Neuteufel

, Novotny

MCA, a monoclonal antibody defined breast cancer tumor associated antigen and its relation to CA 15.3. Tumor Biol 1989; 10: 232–42.

Bray

K.D.

, Koda

J.E.

, Gaur

P.K.

Serum levels and biochemical characteristics of cancer associated antigen CA 549, a circulating breast cancer marker. Cancer Res 1987; 47: 5853–60.

Anderson

, Slota

, Kundu

Characterization of monoclonal antibodies to paragloboside and sialosyl-PG and an improved chromatogram binding assay for rapidly identifying antibodies to tumor antigens. J Cell Biochem Suppl 1987; 110: 157.

Papsidero

L.D.

, Croghan

G.A.

, Johnson

E.A.

, Chu

T.M.

Immunoaffinity isolation of ductal carcinoma antigen using monoclonal antibody F36/22. Molec Immunol 1984, 21: 955–60.